Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA
Rottinghaus Scott T. had 1,467 Enanta Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded Aug 8, 2026 · Filed Aug 10, 2026
On Aug 8, 2026, Rottinghaus Scott T. (Chief Medical Officer) had 1,467 Enanta Pharmaceuticals, Inc. shares withheld for tax at US$13.34 for US$19,570, leaving 23,787 shares. Filed Aug 10, 2026 (Form 4).
- Withheld for tax
- 1,467 shares
- Price
- US$13.34
- Value
- US$19,570
- Holding after
- 23,787 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 8, 2026 | Common Stock | Shares withheld for tax | 1,467 | US$13.34 | 23,787 | Direct |
Source
Related
- Enanta Pharmaceuticals, Inc.
- Rottinghaus Scott T.
- Enanta Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Schedule 13G/A · Deep Track Capital, LP · Feb 13, 2026
- Schedule 13G/A · Dapice Joshua J. · Feb 5, 2026